Oren J. Cohen, MD
Chief Medical & Scientific Officer, Quintiles Transnational Corp.
Oren J. Cohen, MD, is Chief Medical & Scientific Officer for Quintiles Transnational Corp., a global contract research organization with over 23,000 employees in 60 countries.
Dr. Cohen also serves as Vice-Chair of Quintiles' Council on Research Ethics, is Consulting Professor of Medicine on the Infectious Diseases faculty at Duke University Medical Center, and serves on the Board of Directors of the MedStar Health Research Institute.
Dr. Cohen is an Alpha Omega Alpha honors graduate of the Duke University School of Medicine.
Dr. Cohen completed an internship and residency in Internal Medicine at the New York Hospital/Cornell University Medical Center, where he served as Assistant Chief Resident in 1989 - 1990; he received the Richard Bowman award for dedication to medicine in 1990.
He served from 1990 - 1991 as Clinical Instructor in Medicine at the New York Hospital's AIDS treatment center.
Dr. Cohen completed his fellowship in Infectious Diseases in 1994 at the National Institute of Allergy and Infectious Diseases (NIAID), and spent seven years conducting basic and clinical HIV/AIDS research as a Fellow, Clinical Associate, and Medical Officer in the NIAID Laboratory of Immunoregulation.
Dr. Cohen was appointed Assistant Director for Medical Affairs at NIAID, where he also served on the Department of Health and Human Services/Henry J. Kaiser Family Foundation Panel on Clinical Practices for the Treatment of HIV Infection, which formulates the national Guidelines for the Use of Antiretroviral Agents.
Dr. Cohen joined Quintiles as a medical advisor in 2001, and was appointed Chief Medical & Scientific Officer in 2004.
industry experience is concentrated in antiviral drug development, with particular emphasis in the areas of HIV, hepatitis B and hepatitis C global clinical trials.
is the author of more than 50 scientific papers and book chapters, and holds a U.S. patent for HIV-related peptides derived from HIV-infected long-term non-progressors.